Dermata Therapeutics, Inc. (DRMA, DRMAW) (CIK 0001853816) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001493152-26-003812
- Form
- CORRESP
- Filer
- Dermata Therapeutics, Inc. (DRMA, DRMAW) (CIK 0001853816)
- CIK
- 0001853816
- Ticker
- DRMA, DRMAW
- Filed
- 2026-01-27
- SIC industry
- 2834
- HQ
- San Diego, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1853816/000149315226003812/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer